Xeris Biopharma Holdings, Inc. XERS Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s change in lease liabilities?
- Xeris Biopharma Holdings, Inc. (XERS) reported change in lease liabilities of -$434K in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s change in lease liabilities changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s change in lease liabilities decreased by 23.3% year-over-year, from -$352K to -$434K.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.